During an assessment of Residential substance misuse services
Cassiobury Court is a 24-bed residential drug and alcohol service based in Watford, which opened in 2013. The service provides detoxification and rehabilitation for both males and females. Cassiobury Court provides medically monitored detoxification and evidence-based treatments, including 12- step treatment and cognitive-behavioural therapy (CBT) to support people in their recovery.
Cassiobury Court Limited is registered with Care Quality Commission to provide:
- Treatment of disease, disorder or injury
- Accommodation for persons who require treatment for substance misuse.
We carried out an unannounced inspection on 6 and 9 October 2025 to follow up on an action plan from the previous inspection. At the time of inspection there was a registered manager in post. We previously inspected the service in 2018 and rated the service as requires improvement. At the last inspection we found 3 breaches in regulation 10 (dignity and respect), regulation 12 (safe care and treatment), and regulation 17 (good governance). At this inspection we found no breaches.
At this inspection we rated the service as good. The environment was clean and tidy. People had a face-to-face assessment with a nurse and with a prescriber on admission. Staff were able to identify people at risk of abuse and neglect and knew how to escalate safeguarding concerns. There was naloxone available in case of an emergency. There were first aid kits and emergency grab bags. Ligature cutters were easily accessible around the building. There were disabled access bedrooms and appropriate aids to support people. People told us they felt safe at Cassiobury Court and told us that staff were caring and supportive. We observed staff being compassionate and caring towards people in treatment.
However, whilst we noted improvement from our last inspection, there continued to be some areas that needed to be addressed. GP summaries were not always present in care records due to people refusing consent to share information with their GP. Therefore, GP summaries were not always accessed prior to a person starting treatment. Assessment tools used to monitor alcohol withdrawal were not always consistently completed for the first 3 days of treatment. Risk assessments were not always updated following a change in risk.